What is Nanomedicine?
Nanomedicine is the application of Nanotechnology (materials with sizes in the nanometre range, i.e. 10-9 m) to promote innovation in Healthcare. Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Pharmacy, Physics, Biology, Chemistry and Medicine to treat conditions and diseases of the human body at a molecular level. Nanomedicine has many applications, from drug therapy and diagnostics to individual cell repair, to artificial tissues and radiation therapy. The NANOMED EMJMD is focusing on the Drug Delivery applications of Nanomedicine.
What is an EMJMD?
Erasmus Mundus Joint Master Degrees (EMJMDs) are highly integrated study programmes that are delivered by an international Consortium of Higher Education Institutions. They aim at fostering excellence, innovation, and internationalisation in Higher Education Institutions. EMJMDs are supported by the EACEA (Education, Audiovisual and Culture Executive Agency) of the European Commission and are part of the Erasmus + programme.
You can participate to an EMJMD as a scholarship student or as a self-funded student. To learn more about the application procedure please click here.
The NANOMED EMJMD is a Master programme exclusively taught in English that spreads over 23 months. It offers high quality education in the emerging field of Nanomedicine with a strong emphasis on multidisciplinarity. Designing nanomedicines for drug delivery requires to combine knowledge from various fields such as Pharmacy, Biology, Chemistry, Medicine, Physics or Engineering, which is why our Master programme value students from different backgrounds. The NANOMED EMJMD provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final internship (Semester 4, 30 ECTS).